ANIMATION

Curosurf Intratracheal Suspension

Share this article with:

Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis. Curosurf (poractant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.

Share It:
Contact XVIVO

Client


Cornerstone Therapeutics

Working with XVIVO was an excellent choice, we are so happy with the finished animation. It was particularly satisfying showing it to the executive team and hearing, ‘it looks marvelous’.

Senior Researcher, FrieslandCampina